Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow-up from the UK Haemophilia Centre Doctors' Organisation (UKHCDO).
Caroline WallHua XiangBen PalmerElizabeth A ChalmersPratima ChowdaryPeter W CollinsSimon FletcherGeorgina W HallDaniel P HartMary MathiasPaul SartainSusan ShapiroDavid StephensenKate TalksCharles R M Haynull nullPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Emicizumab prophylaxis is associated with sustained low bleeding rates and was generally well-tolerated in people with haemophilia A and inhibitors.
Keyphrases